Aprea Therapeutics, Inc. APRE Q1 2025 earnings

FAQ

When did Aprea Therapeutics, Inc. report Q1 2025 earnings?

Aprea Therapeutics, Inc. (APRE) reported Q1 2025 earnings on May 14, 2025 before market open.

What were Aprea Therapeutics, Inc.'s Q1 2025 revenue and EPS?

Aprea Therapeutics, Inc. reported revenue of $162.5K and eps of $-0.66 for Q1 2025.

Did Aprea Therapeutics, Inc. beat estimates in Q1 2025?

EPS missed the consensus estimate of $-0.65 by $0.01.

How did Aprea Therapeutics, Inc.'s Q1 2025 results compare year-over-year?

Compared to the same quarter a year prior, revenue declined 57.3% from $380.6K a year earlier and eps grew 1.5% from $-0.67.

Where can I find Aprea Therapeutics, Inc.'s Q1 2025 SEC filings?

You can read the 8-K earnings release (0001558370-25-007665) and the 10-Q periodic report (0001558370-25-007667) directly on SEC EDGAR. The filing index links above go to sec.gov.